Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?By: Daniel Shoreson November 11, 2020 at 9:15 pm Publication: IPWatchdog.com | Patents & Patent Law

As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the vaccine (messenger RNA, or mRNA) has taken center stage. Last month, Moderna Therapeutics, one of the global leaders in the race to produce a COVID-19 vaccine using  Read More>>

Categories   Business, Guest Contributors, IP News, Licensing, Patents, Technology & Innovation, COVID-19, Guest Contributor, innovation, intellectual property, Moderna, mRNA, patent, Patent pledge, patents, Pfizer, vaccine